DILFUZA MAKHMUDOVA: Open Payments
NPI 1972269132 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 144 payments from 29 companies in 2025. Trend: 2023 $2,246 · 2024 $3,060 · 2025 $2,497
Food & beverage: $2,497
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $367 |
| ABBVIE INC. | 22 | $331 |
| AstraZeneca Pharmaceuticals LP | 9 | $247 |
| Lilly USA, LLC | 13 | $209 |
| GlaxoSmithKline, LLC. | 14 | $188 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $147 |
| Almatica Pharma LLC | 5 | $108 |
| Exact Sciences Corporation | 5 | $100 |
| Corcept Therapeutics | 5 | $94 |
| Amgen Inc. | 5 | $89 |
Products named: JARDIANCE, VRAYLAR, Wegovy, FARXIGA, TRELEGY ELLIPTA, Ozempic, MOUNJARO, LOREEV XR.
Industry payments across OH — which companies pay providers there.
